1. Igarashi, M. et al. Caprazamycins A-F, novel anti-TB antibiotics, from Streptomyces sp. Abstracts of papers of 42nd Intersci. Conf. Antimicrob. Agents Chemother., No. 232 (F-2031), San Diego (2002).
2. Igarashi, M. et al. Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. J. Antibiot. 56, 580–583 (2003).
3. Doi, N. et al. The novel nucleoside antibiotic caprazamycin B and its derivatization aiming at a new anti-TB drug. [Part 1] In vitro anti-mycobacterial activity of caprazamycin B. Abstracts of 35th Union World Conf. Lung Health, No. PS-586-657, Paris (2004).
4. Doi, N. et al. The novel nucleoside antibiotic caprazamycin B and its derivatization aiming at a new anti-TB drug. [Part 2] In vivo anti-mycobacterial activity of caprazamycin B. Abstracts of 35th Union World Conf. Lung Health, No. PS-591-661, Paris (2004).
5. Kimura, K. & Bugg, T. D. H. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. Nat. Prod. Rep. 20, 252–273 (2003).